Neuromyelitis optica (NMOSD) trials in Netherlands
1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Where
- Rotterdam
- Age
- 2 years to 17 years
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00